The development of cell and gene therapies has become an essential component of cancer and genetic disease research and treatment. Consequently, regulatory approvals for cell and gene therapy have begun to increase globally. As a result, cell and gene therapy research has expanded into other areas of medicine, such as treatments for autoimmune and dermatological diseases.
Winners of the 2021 Life Science Industry Awards for Innovation
December 9, 2021 12:13 pm
COVID-19 Testing at the Community Level – Digital PCR is a Key Tool
March 30, 2021 11:47 am
CRISPR: Saving the World or Playing with Dynamite?
October 27, 2020 2:01 pm
Your Data and Privacy
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.